BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32361007)

  • 1. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
    Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
    de Leeuw ALMP; Giralt J; Tao Y; Benavente S; France Nguyen TV; Hoebers FJP; Hoeben A; Terhaard CHJ; Wai Lee L; Friesland S; Steenbakkers RJHM; Tans L; Heukelom J; Kayembe MT; van Kranen SR; Bartelink H; Rasch CRN; Sonke JJ; Hamming-Vrieze O
    Radiother Oncol; 2024 Jul; 196():110281. PubMed ID: 38636708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of
    Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
    [No Abstract]   [Full Text] [Related]  

  • 4. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.
    Bhide SA; Davies M; Burke K; McNair HA; Hansen V; Barbachano Y; El-Hariry IA; Newbold K; Harrington KJ; Nutting CM
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1360-8. PubMed ID: 20338474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Pretreatment and 3-Month
    Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
    Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.
    Madani I; Duthoy W; Derie C; De Gersem W; Boterberg T; Saerens M; Jacobs F; Grégoire V; Lonneux M; Vakaet L; Vanderstraeten B; Bauters W; Bonte K; Thierens H; De Neve W
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):126-35. PubMed ID: 17448871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A feasibility study on adaptive
    Schatteman J; Van Gestel D; Berwouts D; De Gersem W; De Kerf G; De Neve W; De Ost B; Olteanu AML; Rottey S; Vercauteren T; Goethals I; Duprez F
    Strahlenther Onkol; 2018 Aug; 194(8):727-736. PubMed ID: 29556677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of [
    Pisani C; Vigna L; Mastroleo F; Loi G; Amisano V; Masini L; Deantonio L; Aluffi Valletti P; Sacchetti G; Krengli M
    Radiat Oncol; 2021 Mar; 16(1):57. PubMed ID: 33743759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
    Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P
    Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
    van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
    BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
    van den Bosch S; Dijkema T; Philippens MEP; Terhaard CHJ; Hoebers FJP; Kaanders JHAM; Oyen WJG
    Radiother Oncol; 2019 Jan; 130():39-45. PubMed ID: 30005954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
    Conessa C; Hervé S; Foehrenbach H; Poncet JL
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):628-35. PubMed ID: 15330142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic imaging biomarkers of postradiotherapy xerostomia.
    Cannon B; Schwartz DL; Dong L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.